Introduction
and the renal artery to the internal iliac artery. After declamping, two small patches of bluish discoloration Although the efficacy of cyclosporin (CsA) as an of the graft were noted, which did not increase and immunosuppressant is undisputed, the problem of there was adequate diuresis. One hour after the ananephrotoxicity continues to cause concern. CsA can stomosis, a graft biopsy was taken. lead to a wide spectrum of renal damage. The developPost-operatively the urine output was 2100 ml on ment of cyclosporin-induced haemolytic-uraemic syn-D 0, 1800 ml on D +l, decreasing to 700 ml on D +2, drome (HUS ) was initially reported in bone marrow and subsequently the patient became oliguric. Serum transplant recipients. De novo cyclosporin-induced creatinine increased from 6.0 mg/dl to 10.2 mg/dl and HUS has also been described in a limited number of patient required dialytic support. Ultrasonography renal allograft recipients [1] [2] [3] [4] . We report a patient ( USG) of graft revealed no abnormality. 99mTc diethywho developed HUS after a single intravenous injection lenetriamine penta-acetic acid scan showed normal of CsA. A 1-h graft biopsy showed characteristic perfusion. Prothrombin time (PT ) was 13 s (control changes, and the patient recovered after CsA 17) and partial thromboplastin time was 35 s (control withdrawal. 50). Platelet count decreased to 50 000/mm3 and Hb dropped to 5.8 g/dl on the third day. Peripheral smear showed anisopoikilocytosis with fragmented red cells.
Case
Reticulocyte count was 10%. Serum fibrinogen was 300 mg/dl (normal 200-400 mg/dl ), fibrin degradation A 30-year-old male with chronic renal failure result-products were not detectable, plasma Hb was 11 mg/dl ing from mesangiocapillary glomerulonephritis was (normal 1-5 mg/dl ). Peroperative graft biopsy (report referred to this centre for renal transplantation. He received on D +4 ) showed fibrin thrombi in all 25 received eight sessions of haemodialysis prior to trans-glomeruli. There was mild interstitial oedema with plantation. No blood transfusions were given. Pre-normal tubules ( Figure 1 ). Repeat USG did not reveal transplant evaluation showed a Hb of 8.0 g/dl, total leukocyte count of 6500/mm3 with a normal differential count and a platelet count of 1.9×105/mm3. Blood group was A+ve and there were no cold agglutinins in the serum. The kidney donor was the patient's 40-year-old brother, who had the same blood group with a 50% HLA match.
The increasing graft size. A cross-match test was repeated rejection, the most striking feature is an endovasculitis characterized by intimal mononuclear cell infiltration, and was negative. The patient was given injection methylprednisolone 500 mg for 3 days but graft subendothelial foam cells, and myoblastic proliferation [2] . In the present case these features were not seen. function did not improve. On D +6, when the PT and PTT normalized and platelet count was 90 000/mm3, a There was no evidence of infection, malignant hypertension, or systemic illness like scleroderma which second graft biopsy was done. Biopsy showed 29 glomeruli, many of which showed segmental fibrinoid could have caused HUS. The patient developed HUS possibly as a side-effect of CsA treatment. necrosis of the tuft along with few fibrin thrombi in capillaries. Endothelial cell swelling was seen in glomer-
The development of post-transplant HUS seems to have been a rare event prior to the use of CsA. Giroux ular tufts. One of the afferent arterioles showed endothelial swelling with occlusion of the lumen. There et al. [2] did not observe a single case of de novo HUS in renal allograft recipients receiving azathioprine was no interstitial oedema and no endovasculitis (Figure 2) . and prednisolone. Only eight cases of graft failure associated with microangiopathic haemolytic anaemia At this stage CsA-induced HUS was suspected. CsA was stopped on the 10th post-transplant day and (MAHA) have been reported prior to the use of CsA in renal-transplant recipients, and the MAHA seemed azathioprine was increased to 2.5 mg/kg. Urine output improved gradually and was 1800 ml on 18th post-to be secondary to acute rejection in all but one case [5] [6] [7] . Since the introduction of CsA the number of transplant day. On the 22nd day the patient had a sudden decrease in urine output along with graft cases described has increased [1] [2] [3] [4] . CsA has been shown to be directly toxic to cultured endothelial cells, tenderness. Kidney biopsy was undertaken, and showed only one glomerulus, which was unremarkable. and the reduction of prostacyclin and increased thromboxane A2 and endothelin by CsA may contribute to There was interstitial oedema, lymphomononuclear infiltrate, and marked tubulitis, suggesting acute rejec-the development of HUS [8] .
CsA-induced HUS can present over a variable period tion. A large artery included in the biopsy did not show evidence of vasculitis. The patient was given of time. It is commonly seen between the 2nd to 4th week post-transplant [2] . Van Buren et al. [1] described injection methylprednisolone 500 mg i.v. for 3 days. Gradually the serum creatinine decreased to 2.3 mg/dl a case who was diagnosed on the 3rd post-operative day. In our patient the peroperative graft biopsy done on 31st post-transplant day and patient was discharged. At discharge, Hb was 8.8 g/dl, platelet count was 1 h after the anastomosis showed fibrin thrombi. Prior to this, the patient had received a single dose of CsA 2.5×l05/mm3. Two and a half years post-transplant, serum creatinine is 1.9 mg/dl and Hb is 13.0 g/dl, with 3 mg/kg i.v. He also had primary graft failure associated with MAHA and thrombocytopenia. The presence a normal platelet count.
of thrombi on peroperative biopsy and subsequent detection of MAHA cannot be dissociated in the Discussion present case. Although glomerular thrombi can be seen on peroperative graft biopsy in patients receiving CsA in the absence of HUS, development of primary graft In the immediate post-transplant period, it is very dysfunction has so far only been reported in such difficult to differentiate accelerated rejection from de instances in association with acute vascular rejection novo HUS, both clinically as well as histologically. In or ABO incompatibility [9, 10] . We therefore feel that both, the major damage occurs in blood vessels.
our patient developed HUS after a single intravenous Haemolysis and some degree of thrombocytopenia can injection of CsA; this has not previously been described be present secondary to rejection. In acute vascular in the literature. The changes of HUS were also present in the second graft biopsy, done on the 6th postoperative day when the patient was still on CsA. HUS resolved only after withdrawal of the drug. CsA-induced HUS generally occurs during the first few weeks after transplantation when higher doses of CsA are administered [2] . An association between high panel-reactive antibody levels and thrombotic microangiopathy has been reported [11] but this was not tested in the present case. Intravenous CsA preparations contain cremophor EL (polyoxyethylated castor oil ), which has been reported to cause anaphylactoid reactions; other adverse effects are the same as those of the oral preparation. CsA-induced HUS can be a devastating complication, as it may fail to resolve after CsA withdrawal [2] . Some cases have improved following either withdrawal or even reduction in dosage of the drug. Thrombocytopenia, the severity of which Fig 2. A glomerulus with segmental tuft necrosis (÷) (H&E ×550). usually corresponds with the degree of anaemia, may 4. Morozumi K, Thiel G, Albert FW, Banfi G, Gudat F, Mihatsch improve independently of renal function and may MJ. Studies on morphological outcome of cyclosporine associdisplay spontaneous resolution long before the recovated arteriopathy after discontinuation of cyclosporine in renal ery of renal function [1] . CsA has also been successfully 
